Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.

Zhang Z, Li F, Li Y, Xie Z, Du J, Mao N, Li S, Liu Y, Ge Y, Wang J, Tang Q, Kang J, Peng X, Cheng W, Li Y, Xu P, Xiao Y, Tu T, Xie X, Liu Q

Open source

DOI: 10.1136/lupus-2026-001981
Published: 2026 May 20
Container: Lupus science & medicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/lupus-2026-001981,
  title = {Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.},
  author = {Zhang Z and Li F and Li Y and Xie Z and Du J and Mao N and Li S and Liu Y and Ge Y and Wang J and Tang Q and Kang J and Peng X and Cheng W and Li Y and Xu P and Xiao Y and Tu T and Xie X and Liu Q},
  year = {2026},
  journal = {Lupus science \& medicine},
  doi = {10.1136/lupus-2026-001981},
  url = {https://doi.org/10.1136/lupus-2026-001981}
}

RIS

TY  - JOUR
TI  - Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.
AU  - Zhang Z
AU  - Li F
AU  - Li Y
AU  - Xie Z
AU  - Du J
AU  - Mao N
AU  - Li S
AU  - Liu Y
AU  - Ge Y
AU  - Wang J
AU  - Tang Q
AU  - Kang J
AU  - Peng X
AU  - Cheng W
AU  - Li Y
AU  - Xu P
AU  - Xiao Y
AU  - Tu T
AU  - Xie X
AU  - Liu Q
PY  - 2026
JO  - Lupus science & medicine
DO  - 10.1136/lupus-2026-001981
UR  - https://doi.org/10.1136/lupus-2026-001981
ER  -

APA

Z, Z., F, L., Y, L., Z, X., J, D., N, M., S, L., Y, L., Y, G., J, W., Q, T., J, K., X, P., W, C., Y, L., P, X., Y, X., T, T., X, X., & Q, L. (2026). Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.. Lupus science & medicine. https://doi.org/10.1136/lupus-2026-001981

Source records

pubmed · retrieved 2026-11-10T13:02:57.533Z
europe-pmc · retrieved 2026-11-10T13:02:57.549Z
doaj · retrieved 2026-11-10T13:02:57.534Z